[{"address1": "12730 High Bluff Drive", "address2": "Suite 400", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 500 8800", "website": "https://kuraoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Dr. Troy Edward Wilson J.D., Ph.D.", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1296258, "exercisedValue": 1234936, "unexercisedValue": 15624}, {"maxAge": 1, "name": "Ms. Kathleen  Ford", "age": 77, "title": "Chief Operating Officer", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 868935, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Teresa Brophy Bair Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 745021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Doyle", "age": 53, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francis J. Burrows Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roger  Bakale Ph.D.", "title": "Senior Vice President of Manufacturing & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maureen  Clancy M.B.A.", "title": "VP and Global Head of Program Leadership & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mollie  Leoni M.D.", "age": 46, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Powl M.B.A., M.S.", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Samir  Vattompadam M.S.", "title": "Senior Vice President of Global Program Leadership", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.6, "open": 7.05, "dayLow": 7.035, "dayHigh": 7.75, "regularMarketPreviousClose": 6.6, "regularMarketOpen": 7.05, "regularMarketDayLow": 7.035, "regularMarketDayHigh": 7.75, "payoutRatio": 0.0, "beta": 0.403, "forwardPE": -2.7490637, "volume": 4320605, "regularMarketVolume": 4320605, "averageVolume": 1416127, "averageVolume10days": 1960180, "averageDailyVolume10Day": 1960180, "bid": 7.3, "ask": 7.36, "bidSize": 2, "askSize": 3, "marketCap": 637091456, "fiftyTwoWeekLow": 5.41, "fiftyTwoWeekHigh": 21.569, "priceToSalesTrailing12Months": 7.6500854, "fiftyDayAverage": 6.2251, "twoHundredDayAverage": 8.1507, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 25836338, "profitMargins": -2.36761, "floatShares": 64340149, "sharesOutstanding": 86797200, "sharesShort": 7906891, "sharesShortPriorMonth": 7859540, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0911, "heldPercentInsiders": 0.011460001, "heldPercentInstitutions": 0.95859003, "shortRatio": 6.05, "shortPercentOfFloat": 0.0913, "impliedSharesOutstanding": 86797200, "bookValue": 3.52, "priceToBook": 2.0852273, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -197172000, "trailingEps": -2.25, "forwardEps": -2.67, "enterpriseToRevenue": 0.31, "enterpriseToEbitda": -0.118, "52WeekChange": -0.6351889, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 7.34, "targetHighPrice": 40.0, "targetLowPrice": 11.0, "targetMeanPrice": 27.0, "targetMedianPrice": 27.0, "recommendationMean": 1.35714, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 630728000, "totalCashPerShare": 7.267, "ebitda": -218828000, "totalDebt": 19473000, "quickRatio": 5.928, "currentRatio": 6.159, "totalRevenue": 83279000, "debtToEquity": 6.374, "revenuePerShare": 0.954, "returnOnAssets": -0.22933, "returnOnEquity": -0.5111, "grossProfits": -114831000, "freeCashflow": -57676124, "operatingCashflow": 124987000, "grossMargins": -1.3788699, "ebitdaMargins": -2.6276503, "operatingMargins": -4.75314, "financialCurrency": "USD", "symbol": "KURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Kura Oncology, Inc.", "marketState": "CLOSED", "shortName": "Kura Oncology, Inc.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "corporateActions": [], "postMarketTime": 1755302172, "regularMarketTime": 1755288002, "exchange": "NMS", "messageBoardId": "finmb_282774456", "market": "us_market", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1442410200000, "postMarketChangePercent": 2.99727, "postMarketPrice": 7.56, "postMarketChange": 0.22, "regularMarketChange": 0.74, "regularMarketDayRange": "7.035 - 7.75", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1416127, "fiftyTwoWeekLowChange": 1.9300003, "fiftyTwoWeekLowChangePercent": 0.35674682, "fiftyTwoWeekRange": "5.41 - 21.569", "fiftyTwoWeekHighChange": -14.229, "fiftyTwoWeekHighChangePercent": -0.65969676, "fiftyTwoWeekChangePercent": -63.518887, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754598600, "earningsCallTimestampEnd": 1754598600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.25, "epsForward": -2.67, "epsCurrentYear": -2.18288, "priceEpsCurrentYear": -3.3625305, "regularMarketChangePercent": 11.2121, "regularMarketPrice": 7.34, "fiftyDayAverageChange": 1.1149001, "fiftyDayAverageChangePercent": 0.17909755, "twoHundredDayAverageChange": -0.81069946, "twoHundredDayAverageChangePercent": -0.09946379, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Kura Oncology", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]